These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36915194)

  • 21. The subcellular distribution of eukaryotic translation initiation factor, eIF-5A, in cultured cells.
    Shi XP; Yin KC; Zimolo ZA; Stern AM; Waxman L
    Exp Cell Res; 1996 Jun; 225(2):348-56. PubMed ID: 8660923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis of eIF-5A in lung adenocarcinomas.
    Chen G; Gharib TG; Thomas DG; Huang CC; Misek DE; Kuick RD; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
    Proteomics; 2003 Apr; 3(4):496-504. PubMed ID: 12687616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-protein-interaction network organization of the hypusine modification system.
    Sievert H; Venz S; Platas-Barradas O; Dhople VM; Schaletzky M; Nagel CH; Braig M; Preukschas M; Pällmann N; Bokemeyer C; Brümmendorf TH; Pörtner R; Walther R; Duncan KE; Hauber J; Balabanov S
    Mol Cell Proteomics; 2012 Nov; 11(11):1289-305. PubMed ID: 22888148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translation initiation factor eIF-5A expressed from either of two yeast genes or from human cDNA. Functional identity under aerobic and anaerobic conditions.
    Schwelberger HG; Kang HA; Hershey JW
    J Biol Chem; 1993 Jul; 268(19):14018-25. PubMed ID: 8314769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas.
    Kerekatte V; Smiley K; Hu B; Smith A; Gelder F; De Benedetti A
    Int J Cancer; 1995 Feb; 64(1):27-31. PubMed ID: 7665244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the hypusinylated eukaryotic translation factor eIF-5A bound to the ribosome.
    Schmidt C; Becker T; Heuer A; Braunger K; Shanmuganathan V; Pech M; Berninghausen O; Wilson DN; Beckmann R
    Nucleic Acids Res; 2016 Feb; 44(4):1944-51. PubMed ID: 26715760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway.
    Schwentke A; Krepstakies M; Mueller AK; Hammerschmidt-Kamper C; Motaal BA; Bernhard T; Hauber J; Kaiser A
    BMC Microbiol; 2012 Jun; 12():107. PubMed ID: 22694849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
    Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant Trichomonas vaginalis eIF-5A protein expressed from a eukaryotic system binds specifically to mammalian and putative trichomonal eIF-5A response elements (EREs).
    Carvajal-Gamez BI; Carrillo LV; Torres-Romero JC; Camacho-Nuez M; Ponce-Regalado MD; Camarillo CL; Alvarez-Sánchez ME
    Parasitol Int; 2016 Dec; 65(6 Pt A):625-631. PubMed ID: 27620329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation.
    Pause A; Méthot N; Svitkin Y; Merrick WC; Sonenberg N
    EMBO J; 1994 Mar; 13(5):1205-15. PubMed ID: 8131750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of NSCLC cells to cetuximab through inhibition of eukaryotic translation initiation factor 5A2 activation.
    Wang X; Jiang R; Cui EH; Feng WM; Guo HH; Gu DH; Tang CW; Xue T; Bao Y
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1244-50. PubMed ID: 27097942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxy- adenosine (AbeAdo) treatment on polyamine and eIF-5A metabolism in AbeAdo-sensitive and -resistant L1210 murine leukaemia cells.
    Byers TL; Wiest L; Wechter RS; Pegg AE
    Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):115-21. PubMed ID: 8439281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
    Rousseau D; Kaspar R; Rosenwald I; Gehrke L; Sonenberg N
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1065-70. PubMed ID: 8577715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of mRNA that binds to eukaryotic initiation factor 5A by affinity co-purification and differential display.
    Xu A; Jao DL; Chen KY
    Biochem J; 2004 Dec; 384(Pt 3):585-90. PubMed ID: 15303967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification.
    Liu YP; Nemeroff M; Yan YP; Chen KY
    Biol Signals; 1997; 6(3):166-74. PubMed ID: 9285100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translation initiation factor eIF-5A from Plasmodium falciparum.
    Molitor IM; Knöbel S; Dang C; Spielmann T; Alléra A; König GM
    Mol Biochem Parasitol; 2004 Sep; 137(1):65-74. PubMed ID: 15279952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypusine modification in eukaryotic initiation factor 5A in rodent cells selected for resistance to growth inhibition by ornithine decarboxylase-inhibiting drugs.
    Tome ME; Gerner EW
    Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):55-60. PubMed ID: 8947467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes.
    Bevec D; Klier H; Holter W; Tschachler E; Valent P; Lottspeich F; Baumruker T; Hauber J
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10829-33. PubMed ID: 7971969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.